Skip to content

Pixium Vision

Request correction

Pixium Vision SA was a Paris-based company whose assets, including late-stage macular degeneration clinical trials, were acquired by Science Corporation.

Last updated September 16, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Pixium Vision SA was a company in Paris, France. Its assets, including ongoing clinical trials in late-stage macular degeneration, were acquired by Science Corporation. The sponsor of the European clinical trials and legal manufacturer of the PRIMA device is La Science SAS.

History

Pixium Vision SA was a company in Paris, France. Its assets, including ongoing clinical trials in late-stage macular degeneration, were acquired by Science Corporation. The sponsor of the European clinical trials and legal manufacturer of the PRIMA device is La Science SAS.

Products and positioning

  • PRIMA device

Recent events

  • Reported

    Pixium Vision appoints Offer Nonhoff as CFO[3]

    Pixium Vision announced the appointment of Offer Nonhoff as Chief Financial Officer, effective immediately.

Read more

Sources3 sources

Cite this profile: Cite the canonical profile. /brand-wiki/pixium-vision-france · Editorial policy · How profiles are compiled